Contact UsQuotation
Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

Sucrose octasulfate

Catalog No. T213893 Copy Product Info
🥰Excellent
Sucrose octasulfate, a sulfated oligosaccharide derivative, functions as an inhibitor of matrix metalloproteinases (MMPs). This compound stimulates somatostatin-like immunoreactivity (SLI) release from the stomach by directly targeting D cells in the gastric mucosa. By releasing endogenous gastric somatostatin, sucrose octasulfate promotes ulcer healing. It serves as a pharmaceutical excipient, significantly enhancing wound closure in neuroischemic diabetic foot ulcers and venous leg ulcers. Additionally, sucrose octasulfate is applicable in research related to chronic wound healing.

Sucrose octasulfate

Copy Product Info
🥰Excellent
Catalog No. T213893

Sucrose octasulfate, a sulfated oligosaccharide derivative, functions as an inhibitor of matrix metalloproteinases (MMPs). This compound stimulates somatostatin-like immunoreactivity (SLI) release from the stomach by directly targeting D cells in the gastric mucosa. By releasing endogenous gastric somatostatin, sucrose octasulfate promotes ulcer healing. It serves as a pharmaceutical excipient, significantly enhancing wound closure in neuroischemic diabetic foot ulcers and venous leg ulcers. Additionally, sucrose octasulfate is applicable in research related to chronic wound healing.

Sucrose octasulfate
Cas No. 57680-56-5
Other Forms of Sucrose octasulfate:
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Sucrose octasulfate, a sulfated oligosaccharide derivative, functions as an inhibitor of matrix metalloproteinases (MMPs). This compound stimulates somatostatin-like immunoreactivity (SLI) release from the stomach by directly targeting D cells in the gastric mucosa. By releasing endogenous gastric somatostatin, sucrose octasulfate promotes ulcer healing. It serves as a pharmaceutical excipient, significantly enhancing wound closure in neuroischemic diabetic foot ulcers and venous leg ulcers. Additionally, sucrose octasulfate is applicable in research related to chronic wound healing.
Chemical Properties
Molecular Weight982.75
FormulaC12H22O35S8
Cas No.57680-56-5
SmilesO([C@@]1(COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O1)[C@@H]2[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](COS(=O)(=O)O)O2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Sucrose octasulfate | purchase Sucrose octasulfate | Sucrose octasulfate cost | order Sucrose octasulfate | Sucrose octasulfate formula | Sucrose octasulfate molecular weight
TargetMol | Logo

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.